Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Howard S. Hochster, MD
Cancer Institute of New Jersey Rutgers
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Trinitas Hospital and Comprehensive Cancer Center
Elizabeth, New Jersey, United States
Recruiting - Rwjbarnabas Health Jersey City Medical Center
Jersey City, New Jersey, United States
Recruiting - Rwjbarnabas Health - Monmouth Medical Center Southern Campus
Lakewood, New Jersey, United States
Recruiting - Cooperman Barnabas Medical Center (saint Barnabas Medical Center)
Livingston, New Jersey, United States
Recruiting - Rwjbarnabas Health - Monmouth Medical Center
Long Branch, New Jersey, United States
Recruiting - Rwjbarnabas Health - Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
Recruiting - Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Recruiting - Rwjbarnabas Health - Robert Wood Johnson University Hospital
Somerset, New Jersey, United States
Recruiting - Rwjbarnabas Health - Community Medical Center
Toms River, New Jersey, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 May 2023
- Primary completion
- 1 May 2026
- Completion
- 1 May 2027
- Last update posted
- 18 Mar 2026
- Registered enrollment
- 50
- Registry id
- NCT05806931
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.